30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now
United States Biotechnology & Medical Research

Impact Biomedical Inc (IBO)

Track

Over the last 90 days, Impact Biomedical Inc. has seen significant insider selling, with a net value of -$578,353. The majority of this activity stems from a large proposed sale by stockholder DSS INC. totaling over $23 million. Executives also contributed to the net sell-off, with the CFO making multiple sales.
Stock chart
Ticker: IBO Exchange: ASE
Preparing chart...
Download chart Copy chart image Copy link Share to X Share


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Top insiders
Trades
DSS INC.
Stockholder
1 sale — total 23,064,209 USD
Proposed sale 22 Apr 2026
Value US$432,242.40 | Price 290.77 | Shares 80,357
Sale 27 Mar 2026
Value US$1,892,717.81 | Price 263.48 | Shares 27,965
Sale 25 Mar 2026
Value US$961.28 | Price 0.60 | Shares 1,600
Sale 23 Mar 2026
Value US$32,505.00 | Price 0.65 | Shares 50,000
Sale 27 May 2025
Value US$24,529.62 | Price 0.54 | Shares 45,400
Sale 27 May 2025
Value US$24,529.62 | Price 0.54 | Shares 45,400
Sale 22 May 2025
Value US$63,475.96 | Price 0.55 | Shares 115,600
Sale 22 May 2025
Value US$63,475.96 | Price 0.55 | Shares 115,600
Sale 4 Apr 2025
Value US$845,012.88 | Price 0.95 | Shares 890,800
Sale 4 Apr 2025
Value US$172,800.00 | Price 0.96 | Shares 180,000
Sale 3 Apr 2025
Value US$174,019.72 | Price 0.50 | Shares 351,555
Sale 3 Apr 2025
Value US$212,889.79 | Price 0.78 | Shares 273,286
Sale 3 Apr 2025
Value US$203,594.35 | Price 0.58 | Shares 351,631
Sale 2 Apr 2025
Value US$222,954.94 | Price 0.58 | Shares 382,427
Sale 2 Apr 2025
Value US$1,580.88 | Price 0.67 | Shares 2,349
Sale 2 Apr 2025
Value US$134,800.00 | Price 0.67 | Shares 200,000
Sale 2 Apr 2025
Value US$174,300.00 | Price 0.58 | Shares 300,000
Sale 1 Apr 2025
Value US$1,271,071.44 | Price 1.08 | Shares 1,176,918
Sale 1 Apr 2025
Value US$940,550.00 | Price 1.45 | Shares 650,000
Sale 1 Apr 2025
Value US$392,800.00 | Price 0.98 | Shares 400,000
Sale 31 Mar 2025
Value US$308,400.00 | Price 1.03 | Shares 300,000
Sale 27 Mar 2025
Value US$119,254.95 | Price 2.50 | Shares 47,681
Sale 26 Mar 2025
Value US$31,052.70 | Price 3.15 | Shares 9,858
Sale 26 Mar 2025
Value US$151,080.91 | Price 3.13 | Shares 48,281
Sale 21 Mar 2025
Value US$549,846.64 | Price 3.30 | Shares 166,600
Sale 21 Mar 2025
Value US$549,846.64 | Price 3.30 | Shares 166,600
Sale 21 Mar 2025
Value US$549,846.64 | Price 3.30 | Shares 166,600
Sale 20 Mar 2025
Value US$249,350.40 | Price 4.68 | Shares 53,280
Buy 20 Mar 2025
Value US$310.00 | Price 1.55 | Shares 200
Buy 5 Dec 2024
Value US$1,128.90 | Price 2.26 | Shares 500
Sale 2 Dec 2024
Value US$58.00 | Price 2.90 | Shares 20
Buy 27 Nov 2024
Value US$1,305.00 | Price 2.61 | Shares 500
Buy 26 Nov 2024
Value US$1,295.00 | Price 2.59 | Shares 500
Buy 26 Nov 2024
Value US$1,443.75 | Price 2.63 | Shares 550
Sale 18 Nov 2024
Value US$15,085.00 | Price 3.02 | Shares 5,000
Sale 13 Nov 2024
Value US$560.00 | Price 2.80 | Shares 200
Sale 12 Nov 2024
Value US$1,378.50 | Price 2.76 | Shares 500
Buy 18 Sep 2024
Value US$2,330.00 | Price 2.33 | Shares 1,000
Buy 17 Sep 2024
Value US$18,720.00 | Price 2.40 | Shares 7,800
Buy 16 Sep 2024
Value US$134,500.00 | Price 2.69 | Shares 50,000
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date B/S Transaction type Insider and/or position Nb. shares
Price
Value 		Number of shares Price Value Details
2026-04-29 2026-04-22 PrS Proposed sale
3.8
DSS INC.

Stockholder

Large shareholder
80,357
290.77
US$432,242 		80,357 290.77 US$432,242
2026-03-30 2026-03-27 S Sale
Macko Todd D

Chief Financial Officer

Officer
27,965 -34.5%
263.48
US$1,892,718 		27,965 -34.5% 263.48 US$1,892,718
2026-03-30 2026-03-25 S Sale
Macko Todd D

Chief Financial Officer

Officer
7,480 -11.2%
206.34
US$4,428,620 		7,480 -11.2% 206.34 US$4,428,620
2026-03-25 2026-03-23 S Sale
Grady Jason
Non-Executive Director
50,000 -16.7%
0.65
US$32,505 		50,000 -16.7% 0.65 US$32,505
2026-01-06 2025-05-27 S Sale
3.8
DSS, INC.
Large shareholder
45,400 -7.7%
0.54
US$24,530 		45,400 -7.7% 0.54 US$24,530
2025-05-27 2025-05-27 S Sale
3.8
DSS, INC.
Large shareholder
45,400 -100.0%
0.54
US$24,530 		45,400 -100.0% 0.54 US$24,530
2026-01-06 2025-05-22 S Sale
3.8
DSS, INC.
Large shareholder
115,600 -16.4%
0.55
US$63,476 		115,600 -16.4% 0.55 US$63,476
2025-05-27 2025-05-22 S Sale
3.8
DSS, INC.
Large shareholder
115,600 -71.8%
0.55
US$63,476 		115,600 -71.8% 0.55 US$63,476
2025-04-07 2025-04-04 S Sale
3.8
DSS, INC.
Large shareholder
890,800 -84.7%
0.95
US$845,013 		890,800 -84.7% 0.95 US$845,013
2025-04-04 2025-04-04 S Sale
2.0
Chan Heng Fai Ambrose
Non-Executive Director Large shareholder
180,000 -100.0%
0.96
US$172,800 		180,000 -100.0% 0.96 US$172,800
2025-04-07 2025-04-03 S Sale
2.0
Chan Heng Fai Ambrose
Non-Executive Director
351,555 -100.0%
0.50
US$174,020 		351,555 -100.0% 0.50 US$174,020
2025-04-04 2025-04-03 S Sale
2.0
Chan Heng Fai Ambrose
Non-Executive Director Large shareholder
273,286 -60.3%
0.78
US$212,890 		273,286 -60.3% 0.78 US$212,890
2025-04-04 2025-04-03 S Sale
2.0
Chan Heng Fai Ambrose
Non-Executive Director Large shareholder
351,631 -100.0%
0.58
US$203,594 		351,631 -100.0% 0.58 US$203,594
2025-04-04 2025-04-02 S Sale
2.0
Chan Heng Fai Ambrose
Non-Executive Director Large shareholder
382,427 -52.1%
0.58
US$222,955 		382,427 -52.1% 0.58 US$222,955
2025-04-04 2025-04-02 S Sale
2.0
Chan Heng Fai Ambrose
Non-Executive Director Large shareholder
2,349 -0.7%
0.67
US$1,581 		2,349 -0.7% 0.67 US$1,581
2025-04-04 2025-04-02 S Sale
2.0
Chan Heng Fai Ambrose
Non-Executive Director Large shareholder
200,000 -36.1%
0.67
US$134,800 		200,000 -36.1% 0.67 US$134,800
2025-04-04 2025-04-02 S Sale
2.0
Chan Heng Fai Ambrose
Non-Executive Director Large shareholder
300,000 -35.1%
0.58
US$174,300 		300,000 -35.1% 0.58 US$174,300
2025-04-02 2025-04-01 S Sale
2.0
Chan Heng Fai Ambrose
Non-Executive Director Large shareholder
1,176,918 -61.6%
1.08
US$1,271,071 		1,176,918 -61.6% 1.08 US$1,271,071
2025-04-02 2025-04-01 S Sale
2.0
Chan Heng Fai Ambrose
Non-Executive Director Large shareholder
650,000 -25.4%
1.45
US$940,550 		650,000 -25.4% 1.45 US$940,550
2025-04-02 2025-04-01 S Sale
2.0
Chan Heng Fai Ambrose
Non-Executive Director Large shareholder
400,000 -31.9%
0.98
US$392,800 		400,000 -31.9% 0.98 US$392,800
2025-04-02 2025-03-31 S Sale
2.0
Chan Heng Fai Ambrose
Non-Executive Director Large shareholder
300,000 -19.3%
1.03
US$308,400 		300,000 -19.3% 1.03 US$308,400
2025-03-28 2025-03-27 S Sale
3.8
DSS, INC.
Large shareholder
47,681 -4.3%
2.50
US$119,255 		47,681 -4.3% 2.50 US$119,255
2025-03-28 2025-03-26 S Sale
3.8
DSS, INC.
Large shareholder
9,858 -0.9%
3.15
US$31,053 		9,858 -0.9% 3.15 US$31,053
2025-03-28 2025-03-26 S Sale
3.8
DSS, INC.
Large shareholder
48,281 -4.2%
3.13
US$151,081 		48,281 -4.2% 3.13 US$151,081
2025-03-28 2025-03-21 S Sale
3.8
DSS, INC.
Large shareholder
166,600 -12.4%
3.30
US$549,847 		166,600 -12.4% 3.30 US$549,847
2025-03-28 2025-03-21 S Sale
3.8
DSS, INC.
Large shareholder
166,600 -100.0%
3.30
US$549,847 		166,600 -100.0% 3.30 US$549,847
2025-03-28 2025-03-21 S Sale
3.8
DSS, INC.
Large shareholder
166,600 -100.0%
3.30
US$549,847 		166,600 -100.0% 3.30 US$549,847
2025-03-24 2025-03-20 S Sale
3.8
DSS, INC.
Large shareholder
53,280 -100.0%
4.68
US$249,350 		53,280 -100.0% 4.68 US$249,350
2025-03-24 2025-03-20 B Purchase
3.8
DSS, INC.
Large shareholder
200 +0.4%
1.55
US$310 		200 +0.4% 1.55 US$310
2024-12-09 2024-12-05 B Purchase
0.9
Heuszel Frank D

Chief Executive Officer

Executive Director
500 +0.5%
2.26
US$1,129 		500 +0.5% 2.26 US$1,129
2025-03-24 2024-12-02 S Sale
3.8
DSS, INC.
Large shareholder
20 -0.0%
2.90
US$58 		20 -0.0% 2.90 US$58
2024-12-03 2024-11-27 B Purchase
0.9
Heuszel Frank D

Chief Executive Officer

Executive Director
500 +0.5%
2.61
US$1,305 		500 +0.5% 2.61 US$1,305
2024-12-03 2024-11-26 B Purchase
0.9
Heuszel Frank D

Chief Executive Officer

Executive Director
500 +0.5%
2.59
US$1,295 		500 +0.5% 2.59 US$1,295
2024-12-03 2024-11-26 B Purchase
0.9
Heuszel Frank D

Chief Executive Officer

Executive Director
550 +0.6%
2.63
US$1,444 		550 +0.6% 2.63 US$1,444
2024-11-22 2024-11-18 S Sale
3.8
DSS, INC.
Large shareholder
5,000 -8.6%
3.02
US$15,085 		5,000 -8.6% 3.02 US$15,085
2024-11-22 2024-11-13 S Sale
3.8
DSS, INC.
Large shareholder
200 -0.3%
2.80
US$560 		200 -0.3% 2.80 US$560
2024-11-22 2024-11-12 S Sale
3.8
DSS, INC.
Large shareholder
500 -0.9%
2.76
US$1,378 		500 -0.9% 2.76 US$1,378
2024-09-19 2024-09-18 B Purchase
3.8
DSS, INC.
Large shareholder
1,000 +1.7%
2.33
US$2,330 		1,000 +1.7% 2.33 US$2,330
2024-09-18 2024-09-17 B Purchase
3.8
DSS, INC.
Large shareholder
7,800 +15.6%
2.40
US$18,720 		7,800 +15.6% 2.40 US$18,720
2024-09-18 2024-09-16 B Purchase
3.8
DSS, INC.
Large shareholder
50,000 +inf%
2.69
US$134,500 		50,000 +inf% 2.69 US$134,500
Explore more

More insider trading research around Impact Biomedical Inc

More insider trades in United States
Similar Healthcare companies with insider activity
More Pharmaceuticals & Medical Research companies with insider activity
More Biotechnology & Medical Research companies with insider activity
Insider trading in North America